Previous Close | 163.27 |
Open | 163.82 |
Bid | 162.28 x 100 |
Ask | 162.59 x 100 |
Day's Range | 161.70 - 165.26 |
52 Week Range | 126.97 - 220.96 |
Volume | |
Avg. Volume | 204,983 |
Market Cap | 17.37B |
Beta (5Y Monthly) | 0.59 |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
BeiGene, Ltd. ( NASDAQ:BGNE ) is possibly approaching a major achievement in its business, so we would like to shine...
On June 24, 2024, Julia Wang, Chief Financial Officer of BeiGene Ltd (NASDAQ:BGNE), executed a sale of 899 shares of the company at a price of $155.66 per share. This transaction was documented in an SEC Filing. Following this sale, the insider now owns 432,731 shares of BeiGene Ltd.
Argenx (ARGX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.